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Background
Plasmodium vivax Merozoite Surface Protein-1 (MSP-1)
is an antigen considered to be one of the leading malaria
vaccine candidates. PvMSP-1 is immunogenic and evi-
dences suggest that it is a target for protective immunity
against asexual blood stages of malaria parasites. This
study aims to evaluate the acquired cellular and anti-
body immune responses against PvMSP-1 in individuals
exposed to malaria infections in a Brazilian malaria
endemic area.
Methods
The study was carried out in Paragominas, Pará State, in
the Brazilian Amazon. Blood samples were collected from
35 individuals with uncomplicated malaria. Peripheral
blood mononuclear cells were isolated and the cellular
proliferation and activation was analyzed in presence of
19 kDa fragment of MSP-1 (PvMSP-119) and P. falciparum
PSS1 crude antigen. Antibodies IgE, IgM, IgG and IgG
subclass and the levels of TNF-a, IFN-g and IL-10 were
measured by enzyme-linked immunosorbent assay
(ELISA).
Results
The prevalence of activated CD4+was greater than CD8+
T cells, in both ex-vivo and in 96 h culture in presence of
PvMSP-119 and PSS1 antigen. A low proliferative
response against PvMSP-119 and PSS1 crude antigen
after 96 h culture was observed. High plasmatic levels of
IFN-g and IL-10 as well as lower TNF levels were also
detected in malaria patients. However, in the 96 h super-
natant culture, the dynamics of cytokine responses dif-
fered from those depicted on plasma assays; in presence
of PvMSP-119 stimulus, higher levels of TNF were noted
in supernatant 96 h culture of malaria patients’ cells
while low levels of IFN-g and IL-10 were verified. High
frequency of malaria patients presenting antibodies
against PvMSP-119 was evidenced, regardless of class or
IgG subclass. PvMSP-119-induced antibodies were predo-
minantly on non-cytophilic subclasses.
Conclusions
PvMSP-119 was able to induce a high cellular activation,
leading to production of TNF and emphasizes the high
immunogenicity of PvMSP-119 in naturally exposed indi-
viduals and therefore its potential as a malaria vaccine
candidate.
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